Andere Sprachen Johnson & Johnson Börse Stuttgart

Aktien

853260

US4781601046

JNJ

Realtime-Estimate Tradegate Andere Börsenplätze 16:00:41 31.05.2024			% 5 Tage	% 1. Jan.
133,9 ^EUR	-0,27 %		-3,03 %	-5,10 %

15:33	Johnson & Johnson schließt Übernahme von Shockwave Medical ab	MT
30.05.	Sarepta Therapeutics wird Shockwave Medical im S&P MidCap 400 ablösen	MT

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Johnson & Johnson Closes Acquisition of Shockwave Medical	15:33
Sarepta Therapeutics to Replace Shockwave Medical in S&P MidCap 400	30.05.
Transcript : Johnson & Johnson Presents at Bernstein?s 40th Annual Strategic Decisions Conference, May-29-2024 01:30 PM	29.05.
Johnson & Johnson's Phase 3 Trial of Seltorexant to Treat Major Depressive Disorder Meets Primary, Secondary Endpoints	29.05.
J&J's treatment for depression succeeds in late stage study	29.05.
Johnson & Johnson Announces Pivotal Study of Seltorexant Shows Statistically Significant and Clinically Meaningful Improvement in Depressive Symptoms and Sleep Disturbance Outcomes	29.05.
Sector Update: Health Care Stocks Fall Late Afternoon	28.05.
Sector Update: Health Care Stocks Retreat Tuesday Afternoon	28.05.
Sector Update: Health Care	28.05.
Bio-Thera, Stada Enter Deal for Biosimilar Candidate to Johnson & Johnson's Simponi in EU, UK	28.05.
Johnson & Johnson Agrees to Buy Numab Unit, Investigational Skin Disease Treatment For $1.25 Billion	28.05.
Top Midday Stories: Wall Street Returns to T+1 Settlements; T-Mobile Buys US Cellular's Wireless Ops; Energy Transfer Buys WTG Midstream; GameStop Extends Rally	28.05.
Johnson & Johnson to Acquire Experimental Eczema Drug for $1.25 Billion	28.05.
Johnson & Johnson to Acquire Experimental Eczema Drug for $1.25 Billion	28.05.
J&J acquires rights to skin disorder drug for $1.25 bln	28.05.
Cancer victims sue Johnson & Johnson over 'fraudulent' bankruptcies	22.05.
Johnson & Johnson Allegedly Engaged in 'Bad Faith' Bankruptcies That Harm Talc Victims, Lawsuit Says	22.05.
Top Midday Stories: US Targets August 1 Start Date for China Tariff Hikes; CFPB Says BNPL Requires Credit Card-Level Oversight; Target Shares Fall on Earnings Miss; Third BHP Bid Rejected by Anglo American	22.05.
Johnson & Johnson Allegedly Engaged in 'Bad Faith' Bankruptcies That Harm Talc Victims, Lawsuit Says	22.05.
Nanobiotix to Transfer Phase 3 Head and Neck Cancer Study Sponsorship	21.05.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Schlagzeilen

Die Medikamentenpipeline ist für 2024 gut positioniert, sagt J&J CFO

Am 23. Januar 2024 um 18:30 Uhr